Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Thomas A Fleisher, MD
Thomas A. Fleisher, M.D. is the Chief of the Department of Laboratory Medicine in the Clinical Center at the National Institutes of Health (NIH) in Bethesda, MD, USA and directs the diagnostic immunology laboratory within this department. He has also directed the training program in Clinical and Laboratory Immunology within his department for the past 12 years. Dr. Fleisher serves as an allergy consultant to the National Institutes of Allergy and Infectious Diseases at the NIH as well as an adjunct professor in the Department of Pediatrics at the Uniformed Services University of Health Sciences also in Bethesda. He received his pediatric training at the University of Minnesota and his allergy and immunology training at the NIH. His research interests focus on improved and expanded diagnostic methods for immunological disorders and evaluating the underlying immunopathogenic mechanisms that produce the clinical consequences of the autoimmune lymphoproliferative syndrome (ALPS). Dr. Fleisher is currently President of the Clinical Immunology Society and serves on the Board of Directors of the American Academy of Allergy, Asthma and Immunology.
Luigi D Notarangelo
Luigi D. Notarangelo is Professor of Pediatrics at Children's Hospital, University of Brescia, Italy and has served as President of the European Society for Immune Deficiencies since 2002. He has actively contributed to the characterization of the molecular bases of several genetic diseases, including X-linked hyper-IgM syndrome, immunodeficiency with hyper-IgM due to CD40 deficiency, X-linked isolated thrombocytopenia. SCID due to Jak3 deficiency, Omenn syndrome, X-linked lymphoproliferative disease, osteopetrosis, and WHIM syndrome. Dr. Notarangelo has also participated in the development of novel therapeutic approaches to primary immune deficiencies, including the first European trial for gene therapy in adenosine deaminase deficiency and experience with prenatal stem cell transplantation for the correction of severe combined immune deficiency. He is author of over 300 scientific papers in peer-reviewed international Journals and is called upon regularly to lecture at international meetings regarding the basis, diagnosis and management of immune deficiencies.
Dr. Broide received his medical degree from the University of Cape Town in South Africa. He completed an internship at Groote Schuur Hospital in Cape Town, and residency in internal medicine in the Harvard affiliated Peter Bent Brigham/Waltham program in Boston. After completing a fellowship in allergy/immunology at the University of California in San Diego, he joined the faculty of the University of California San Diego where he is currently a Professor of Medicine. Dr. Broide is involved in both basic and translational clinical research. He has authored over 80 publications in the field of mechanisms of asthma and novel therapies for asthma. His basic and translational research program is funded by the National Institutes of Health. He has served on NIH grant review study sections, the American Board of Allergy Immunology, the editorial board of the Journal of Allergy and Clinical Immunology, and is the Allergy section editor of Clinical Immunology.
Dr. Passalacqua was born in Genoa in 1964, graduated in 1990 from the Genoa University Medical School, and received the specialty degrees in Allergy and Clinical Immunology and Respiratory Medicine in 1994 and 2002.
He completed his fellowships at the same university, under the chairmanship of Professor Giorgio Walter Canonica, where he contributed to investigate and develop the new routes of administration of allergen immunotherapy, in particular the sublingual. He was a member of the panel of experts of the European Academy of Allergy and Clinical Immunology that published the position paper on local immunotherapies. Other relevant research fields include allergic inflammation, pharmacokinetics of immunotherapy and epidemiology of allergic diseases.
He is currently assistant professor in pulmonology and allergy at the Allergy and Respiratory Diseases clinic at the University of Genoa. Dr. Passalacqua has authored and co-authored more than 120 publications in peer reviewed journals, along with book chapters, in the field of allergic diseases, non-injection immunotherapy, asthma and rhinitis. He serves on the board of experts of Allergic Rhinitis and its Impact on Asthma (ARIA), and he is one of the editors of the journal Allergy. He currently acts the chair of the Allergy study Group of the Italian Respiratory Medicine Society.